PReGe in Outdoor Fitness Parks (PReGe-BIO)

November 3, 2021 updated by: Fausto Jose Barbero-Iglesias, University of Salamanca

Therapeutic Exercise for Older Adults: Revitalization and Postural Balance in Outdoor Fitness Parks

Older people have been one of the most affected by the Covid-19 pandemic. Restrictive measures to prevent the spread of the virus have affected the lifestyle of older people, which have reduced their level of physical activity. A sedentary lifestyle has negative health consequences, such as increased frailty and decreased functional capacity. The aim of the study is to apply a program of therapeutic exercise in outdoor fitness parks to prevent the complications of sedentary lifestyle. Community-dwelling older adults belonging will participate in an outdoor program to keep security measures and prevent contagion.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salamanca, Spain, 37007
        • Universidad de Salamanca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • People over 60 year who decide to participate voluntarily.
  • Acceptance of Informed Consent.
  • Municipal registration in Salamanca.
  • Responsible declaration of good health.
  • Absence of symptoms compatible with Covid-19.

Exclusion Criteria:

  • Presence of absolute or relative contraindications to physical exercise.
  • Presence of serious balance limitations, such as severe neurological, visual or musculoskeletal disorders.
  • Presence of difficulties to carry out the tests of the Initial Assessment.
  • Participate in another physical activity program.
  • Incidents or pathologies suffered during the intervention that interfere with the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PReGe
Group that will perform the intervention with therapeutic exercise.
There will be two weekly sessions of 45 minutes, outdoors in outdoor fitness parks. The components of balance, gait, resistance, strength and elasticity will be worked on and breathing exercises will be performed. The sessions will be guided and dosed by physiotherapists, considering the level of perception of effort. Indications will be given to carry out other sessions of 60 to 120 minutes of therapeutic walking (minimum speed of 4 km/hour) during the week, to complete the 150-300 minutes per week of physical activity recommended by the WHO.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Physical Performance Battery (SPPB)
Time Frame: Change from baseline to 16 weeks follow-up.

A validated test to identify frail older adults. The score ranges from 0 to 12 points.

The lowest scores are for people with the highest degree of frailty.

Change from baseline to 16 weeks follow-up.
2 minute stair test
Time Frame: Change from baseline to 16 weeks follow-up.
Test that evaluates cardiorespiratory endurance. There are reference tables that provide a percentile of resistance based on the age and gender of the participant.
Change from baseline to 16 weeks follow-up.
Borg Rating of Perceived Exertion Scale
Time Frame: Change from baseline to 16 weeks follow-up.

Exertion rating based on a 6 to 20 rating scale may provide a fairly good estimate of the actual heart rate during physical activity.

Higher scores imply a greater degree of perceived exertion.

Change from baseline to 16 weeks follow-up.
IPAQ-E Questionnaire
Time Frame: Change from baseline to 16 weeks follow-up.
Questionnaire that evaluates the level of physical activity. The time spent on activities of different intensity during the last 7 days is recorded. The score is calculated in METs-minute-week (MMW). METs refer to a metabolic expenditure rate. A greater number of MMW, greater amount of physical activity is done weekly.
Change from baseline to 16 weeks follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sex
Time Frame: Baseline
Participant's sex will be registered.
Baseline
Date of birth
Time Frame: Baseline
Participant's date of birth will be recorded in order to calculate their age.
Baseline
Medication
Time Frame: Baseline
Information on the medication that each participant is currently taking will be collected to evaluate possible interferences.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fausto J Barbero-Iglesias, PhD, University of Salamanca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2021

Primary Completion (Actual)

August 27, 2021

Study Completion (Actual)

August 27, 2021

Study Registration Dates

First Submitted

May 8, 2021

First Submitted That Met QC Criteria

May 12, 2021

First Posted (Actual)

May 13, 2021

Study Record Updates

Last Update Posted (Actual)

November 11, 2021

Last Update Submitted That Met QC Criteria

November 3, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PReGeUSAL-2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly

Subscribe